Cargando…
Propranolol inhibits stemness of hemangioma through Jagged1
BACKGROUND: Propranolol is used clinically to treat infantile hemangioma (IH), although the exact mechanism that underlies its effectiveness is not fully understood. The Jagged1/Notch signaling pathway is downstream of the β2-adrenergic receptor (β2-AR). Propranolol is a non-selective β2-AR blocker...
Autores principales: | Ma, Xiaorong, Lv, Kaiyang, Wu, Liming, Ouyang, Tianxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667105/ https://www.ncbi.nlm.nih.gov/pubmed/34988191 http://dx.doi.org/10.21037/atm-21-5563 |
Ejemplares similares
-
Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma
por: Xu, Miao, et al.
Publicado: (2021) -
Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023) -
When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)